TAS-102 in metastatic colorectal cancer (mCRC): efficacy, tolerability, and quality of life in heavily pretreated elderly patients: a real-life study

Por Giuseppe Cicero, Raffaele Addeo, Rossella De Luca, Giuseppe Lo Re, Leonardo Gulotta, Pierenrico Marchesa, Gaspare Gulotta
Publicado em 2020-09-01